Navigation Links
Opexa Therapeutics Reports Positive Top-line Data in Phase I/II,Extension Trial with Tovaxin for Multiple Sclerosis

THE WOODLANDS, Texas--(BUSINESS WIRE)--Jun 21, 2007 - Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company involved in the development and commercialization of cell therapies, today announced positive top-line data in an open-label Phase I/II extension clinical trial of the investigational T-cell vaccine, Tovaxin(TM), for multiple sclerosis (MS). In this one-year, 8-subject extension clinical trial of relapsing remitting (RRMS) and secondary progressive (SPMS) subjects, Tovaxin therapy was shown to be safe and effective. The "per-protocol" analysis of Tovaxin therapy achieved a 92% reduction in annualized relapse rate (ARR) in subjects who received two treatment doses of 30 - 45 x 10(6) attenuated T-cells eight weeks apart and were monitored for an additional 44 weeks. Subjects in the extension study had previously been treated an average of 5.2+/-1.8 (1, 8; median 5.4) years earlier at Baylor College of Medicine under the direction of Jingwu Zhang, M.D., Ph.D with a T-cell vaccine developed from myelin basic protein (MBP) reactive T-cells. The safety profile revealed only injection site mild reactions and no severe adverse reactions related to T-cell vaccination.

Both Phase I/II clinical studies have demonstrated that T-cell vaccination depletes myelin reactive T-cells in peripheral blood. In the extension study patient population, the myelin reactive T-cell frequencies were reduced by 84% and 72% at 6 and 12 months on study, respectively. Reductions in myelin reactive T-cell frequencies in the dose escalation study were 76.7% and 64.8% at 6 and 12 months on study, respectively.

All subjects currently are enrolled in a retreatment extension study to collect longitudinal safety and effectiveness data.

Effectiveness data for the 13 RRMS subjects across the two Phase I/II trials showed an 80% reduction in ARR. The Expanded Disability Scoring Scale (EDSS) for the RRMS subjects for a 0.5 point effect was
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Opexa Advances Monocyte Derived Islet Technology to Proof of Principle in stz-induced NOD/SCID Mice
2. Opexa Presents Tovaxin Research at Federation of Clinical Immunology Societies Annual Meeting
3. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Dose Escalation Trial with Tovaxin for Multiple Sclerosis
4. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
5. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
6. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
7. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
8. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
9. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
10. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
11. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
Post Your Comments:
(Date:7/29/2015)... Colo., July 29, 2015 Heska Corporation ... a provider of advanced veterinary diagnostic and other specialty ... quarter ended June 30, 2015. Second Quarter ... Operations was up nearly 100% to $1.829 million, from $917 ... to $10.1 million, from $7.8 million. , Core Companion ...
(Date:7/29/2015)... July 27, 2015 Research and Markets ... the "Global Neurostimulation Devices Market 2015" ... forecast the global neurostimulation devices market to grow ... 2014-2019. The report, Global Neurostimulation Devices ... in-depth market analysis with inputs from industry experts. ...
(Date:7/29/2015)... 29, 2015 At the 2015 AACC ... present findings that a first-of-its-kind smartphone test for ... which could reduce the prevalence of this sexually ... and cheaper. Most people with chlamydia ... often causes no symptoms, but if left untreated, ...
Breaking Medicine Technology:Heska Reports Financial Results for the Second Quarter of 2015 2Heska Reports Financial Results for the Second Quarter of 2015 3Heska Reports Financial Results for the Second Quarter of 2015 4Heska Reports Financial Results for the Second Quarter of 2015 5Heska Reports Financial Results for the Second Quarter of 2015 6Heska Reports Financial Results for the Second Quarter of 2015 7Heska Reports Financial Results for the Second Quarter of 2015 8Global Neurostimulation Devices Market 2015-2019 2First Smartphone DNA Test for Chlamydia to Be Presented at 2015 AACC Annual Meeting 2First Smartphone DNA Test for Chlamydia to Be Presented at 2015 AACC Annual Meeting 3
(Date:7/29/2015)... BC (PRWEB) , ... July 29, 2015 , ... Angelo’s ... of its new service: water damage restoration of carpets and rugs. The company will ... well as for commercial clients. , An overflowing overhead tank, rain leaking through ...
(Date:7/29/2015)... ... 2015 , ... The healthcare analytics market is categorized on ... such as the rising pressure to curb healthcare costs, big data in healthcare, ... investments are driving market growth. Check 149 data tables & 57 figures spread ...
(Date:7/29/2015)... , ... July 29, 2015 , ... ... are anticipating testing regulations imposed by the FDA for nicotine laced liquid products. ... of electronic cigarettes have raised considerably. E-Cigarettes are particularly troublesome to addiction professionals ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... Orthopedic surgeons ... now offer the Rotation Medical Rotator Cuff System, a new implant to treat a ... is designed to foster natural regeneration of additional tendon tissue, which could allow for ...
(Date:7/29/2015)... ... July 29, 2015 , ... CanAm Enterprises, LLC (“CanAm”) is thrilled to announce ... I-829 approvals have been granted to investors in four different CanAm EB-5 projects -- ... project in Philadelphia, and the Valley Forge Convention Center project in CanAm’s regional center ...
Breaking Medicine News(10 mins):Health News:Angelo’s FabriClean Now Offers Water Damage Restoration For Residential and Commercial Accounts 2Health News:Healthcare Analytics Market Growing at 26.5% CAGR to 2020 2Health News:Healthcare Analytics Market Growing at 26.5% CAGR to 2020 3Health News:Healthcare Analytics Market Growing at 26.5% CAGR to 2020 4Health News:Healthcare Analytics Market Growing at 26.5% CAGR to 2020 5Health News:Harbor Village Urges South Florida Residents to Abstain from the Use of E Cigarettes 2Health News:Harbor Village Urges South Florida Residents to Abstain from the Use of E Cigarettes 3Health News:Lourdes Orthopedics First in NJ to Offer Bioinductive Implant for Rotator Cuff Repair 2Health News:Lourdes Orthopedics First in NJ to Offer Bioinductive Implant for Rotator Cuff Repair 3Health News:More Than 60 New I-829 Approvals in Less Than 30 days for CanAm 2Health News:More Than 60 New I-829 Approvals in Less Than 30 days for CanAm 3
... forced to use ,workarounds, to ensure medication errors are kept ... News) -- Flaws in the design and implementation of barcode ... of the right medication can increase the risk of certain ... use of the system in five U.S. hospitals. , ...
... Make Cashless Visits To Seven Star Medica Hospitals, ... health and,safety services company, announced today that it has ... to its seven facilities in,Mexico. HTH Worldwide will now ... Medica facility for those who carry HTH insurance. Star,Medica,s ...
... Pa., July 3 Vibra Healthcare, LLC,("Vibra") announced ... two,specialty hospitals in Southern California. The acquisition included ... freestanding,Long Term Acute Care Hospital -- LTACH) and ... CA (a 60-bed freestanding Acute,Rehabilitation Hospital)., Brad ...
... air pollution,resulting from wildfires poses lethal health hazards ... Residents with respiratory problems such,as asthma, emphysema, and ... take extra precautions during this time and call ... without lung diseases are at risk during this ...
... older drugs as good as newer ones, study ... -- Taking prescription medications can help reduce violent ... , It included 1,445 schizophrenia patients randomly selected ... perphenanize, quetiapine, risperidone or ziprasidone. , Patient violence ...
... Ill., July 3 Hong Ray Enterprises of,Shijiazhuang, China, ... major manufacturer of nitrile gloves, has notified Medline,Industries, Inc., ... conditions" and that they will be unable to meet ... exam glove supplier., "This disruption to supply will ...
Cached Medicine News:Health News:Barcode Technology Flaws Put Some Patients at Risk 2Health News:HTH Worldwide Signs Agreement with Star Medica to Give Travelers to Mexico Top Hospital Care 2Health News:American Lung Association Urges People Living Near Wildfires to Protect Themselves Against Staggering Levels of Unhealthy Air Pollution 2Health News:American Lung Association Urges People Living Near Wildfires to Protect Themselves Against Staggering Levels of Unhealthy Air Pollution 3Health News:Medication Reduces Violence in Some Schizophrenics 2Health News:Medline Receives Force Majeure Notice From Hong Ray Enterprises 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: